AlzheimersDiseaseLibrary

Archive for June, 2010

Alzheimer’s disease has several levels; in general there are three levels or stages. This stage can be lasted sooner or later, depending on each individual patient. Each stage there is a few symptoms. In general, the treatment given at the center of the early symptoms more effectively.

In the first stage, at this stage is called early stage. The signs and symptoms of this disease is loss of memory, forgetting oaring premises known and often have little memory loss. They often forget where their homes, lost the ability to choose the words in communication. The most common is often the case is often lost or forgot to put together personal. In the first phase occurs too behavioral changes such as eating and sleeping problems, confusion, depression and changes in the work to which they usually do.

The second phase, in this stage the symptoms become more serious experienced by sufferers. It is also strongly felt by the family. The most prominent is forgotten by the newly occurred event; forget the history of their own. They are difficult to match faces with names. Confused with days, dates and years. The ability to communicate becomes increasingly worse. They are the easier emotional and often angry, anxious or worried.

In the third stage, at this stage amendments to the level of even worse to the lower. At this stage patients needed help from others for its activities. Because they have difficulty doing routine activities such as eating, drinking, dressing, talking and going to the toilet. They can only lie in bed. In this case the required medical care, because the required 24-hour supervision

Alzheimer’s disease is difficult to diagnose. Still today, the only certain method of diagnosis of Alzheimer’s is through brain biopsy performed after death of patient. What are needed are a forward-looking tests and markers …
With patients living, working methods acceptable for the diagnosis of Alzheimer’s by process of elimination.
Researchers have worked hard to develop methods and markers specific for early detection and early Alzheimer’s process of nerve degeneration.

There was significant progress made in the area of Alzheimer’s diagnosis. Have been discovered genetic indicators, biomarkers are being developed and a brain scan technology continues to improve. A team at the translational Genomics Research Institute in Phoenix, Arizona, has discovered a gene called GAB2. If you have a corrupted version that you are a much higher risk of eventually developing Alzheimer’s.

This can ultimately help us to diagnose Alzheimer’s disease even before it started. Biomarkers. Nanogen, Inc., a San Diego, CA-based advanced technology, working to provide researchers, doctors and physicians with a method that has been repaired and tools to predict, diagnose, and ultimately help treat disease. In early 2007 they announced that it had received two patents relating to the identification of protein biomarkers for Alzheimer’s disease.

Brain scan tests, such as computerized tomography (CT) scan, (the most widely used), Magnetic Resonance Imaging (MRI) scans, or positron emission tomography (PET), Single Photon Emission together with CT (sect) is now used.
Hopefully we’ll soon have better methods for early diagnosis and treatment of Alzheimer’s.